Vireo Growth (VREOF) Interest Coverage Ratio (2020 - 2026)
Vireo Growth (VREOF) posted Interest Coverage Ratio of 0.03 for Q1 2026, up 151.28% sequentially from 0.07 in Q4 2025, and down 86.79% YoY from 0.26 in Q1 2025.
Vireo Growth (VREOF) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Vireo Growth has reported Interest Coverage Ratio for 7 years, with the latest figure at 0.03 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 86.79% year-over-year to 0.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02 (down 94.88% YoY) and the FY2025 annual result came in at 0.04, down 108.63% from the prior year.
- Interest Coverage Ratio rose to 0.03 in Q1 2026 per VREOF's latest filing, from 0.07 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 2.48 in Q4 2023 and troughed at 0.22 in Q1 2022.
- A 5-year average of 0.23 and a median of 0.02 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio tumbled 705.92% in 2023, then soared 15392.9% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 0.1 in 2022, then soared by 2415.9% to 2.48 in 2023, then sank by 104.98% to 0.12 in 2024, then surged by 45.09% to 0.07 in 2025, then jumped by 151.28% to 0.03 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.03, 0.07, and 0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Vireo Growth | 492.35 Mn | 350.05 Mn | 95.30 Mn | -0.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | 0.52 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.24 |
| Dec 31, 2023 | 2.48 |
| Sep 30, 2023 | 0.74 |
| Jun 30, 2023 | -0.12 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | -1.82 |
| Sep 30, 2021 | -0.02 |
| Jun 30, 2021 | -0.04 |